InvestorsHub Logo
Followers 864
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

Re: JetLifer post# 654

Sunday, 11/20/2011 1:23:44 PM

Sunday, November 20, 2011 1:23:44 PM

Post# of 979
Jetlifer. Looking in. BOCX sheet:



VIDEO Presentation: http://biocurex.com/media/burger_scia.wmx

Nov 9, 2011. Wholly Owned Subsidiary, OncoPet Diagnostics, Signs Distribution Agreement With Webster Veterinary
http://ih.advfn.com/p.php?pid=nmona&article=49871177

Ocy 27, 2011. Generates Attention at Recent International Scientific Meeting on Cancer Markers
http://ih.advfn.com/p.php?pid=nmona&article=49692506

Oct 11, 2011. RECAF(TM) Positioned to Solve Issues With PSA Screening
http://ih.advfn.com/p.php?pid=nmona&article=49493626

Oct 4, 2011. Oncology Journal to Publish RECAF(TM) Test Results Showing Very High Sensitivity in Detection of Early Stages of Breast Cancer
http://ih.advfn.com/p.php?pid=nmona&article=49408033

Video presentation by BioCurex Chairman Dr. Denis Burger at the Southern California Investment Association.
http://biocurex.com/media/burger_scia.wmx

Also, Slide presentation by BioCurex Chairman Dr. Denis Burger at the Southern California Investment Association.
http://biocurex.com/media/burger_scia_slides.swf

And, Abbott Labs and BioCurex joint presentation of serum-RECAF results (pdf)
http://biocurex.com/media/posters/Abbott_poster.pdf

Sept 8, 2011 BioCurex's RECAFTM Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies
http://biocurex.com/news/news133.htm

Aug 25, 2011 BioCurex Presents Latest Advances on Its Proprietary Peptide RECAF(TM) Test in International Cancer Congress
http://biocurex.com/news/news132.htm



BioCurex Inc.
Suite 215, 7080 River Road, Richmond, BC, V6X 1X5, Canada
Tel: (866) 884 8669 (Toll free) or (604) 207 9150
Fax (604) 207 9165
email: info@biocurex.com
http://biocurex.com/index.php

10-Q Period Ending June 30, 2011:
http://sec.gov/Archives/edgar/data/1092562/000135448811002730/bocx_10q.htm
SEC FIlings:
http://sec.gov/Archives/edgar/data/1092562/000135448811002730/0001354488-11-002730-index.htm

OncoPet Diagnostics Inc. is a wholly owned subsidiary of BioCurex, Inc., a development stage biotechnology company with proprietary and patented technologies in the area of cancer detection.
http://oncopetdiagnostics.com/index.php
New OncoPet Sample Collection Kit Ready to Ship to Distributors and Veterinarians



http://ih.advfn.com/p.php?pid=nmona&article=49304397&symbol=BOCX

Shares Outstanding 175,177,131 a/o Aug 10, 2011
Float Not Available
http://www.otcmarkets.com/stock/BOCX/company-info

O/S: 174,427,131 (December 31, 2010 - 168,188,974)
A/S: 450,000,000
iHub MB: http://investorshub.advfn.com/boards/board.aspx?board_id=2475

SLIDE SHOW: http://biocurex.com/media/burger_scia_slides.swf

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.